#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant melanoma Fatty acid oxidation disorder Diffuse large B-cell lymphoma Neurodevelopmental disorder Anti-glomerular basement membrane disease Myelodysplastic syndrome B-cell lymphoma Henoch-Schonlein purpura Malignant glioma Leber's congenital amaurosis Neuroendocrine tumour of the lung Facioscapulohumeral muscular dystrophy Juvenile idiopathic arthritis Hormone-dependent prostate cancer Hypocalcaemia More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Diagnostics Von Willebrand’s disease – Trials in Disease Atypical haemolytic uraemic syndrome – Trials in Disease Pleomorphic leiomyosarcoma – Life with Disease Rett syndrome – Trials in Disease Niemann-Pick disease – Life with Disease Loeys-Dietz syndrome – Diagnostics SAPHO syndrome – Diagnostics Encephalitis autoimmune – Treatment Angiosarcoma non-metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZOREVUNERSEN SODIUM SODIUM FUSIDATE Pantoprazole Tinzaparin Sodium Rintatolimod Trastuzumab Deruxtecan FLUORIDE Tebentafusp Fluorodopa (18F) Palopegteriparatide Methylphenidate Hydrochloride Carbamazepine (Ph. Eur.) Siltuximab 7-Ethyl-10-Hydroxycamptothecin Gs-5718-03 Mps-215 Obinutuzumab Meropenem Trihydrate Gadoteric Acid Nilotinib More therapies…

    Learn about Your Condition

    Desmoid tumour Aortic disorder Bipolar disorder Eyelid ptosis Benign prostatic hyperplasia Endometrial cancer stage III Parkinson's disease Electrocorticogram Glucose tolerance impaired Renal cancer recurrent Lymphangioma Mantle cell lymphoma recurrent Plasma cell myeloma recurrent Juvenile absence epilepsy Melanoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Long-term safety study of GD2IL18CART treatment in patients with neuroblastoma, osteosarcoma, Ewing sarcoma, or advanced breast cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • Gd2Il18Cart
    Germany

  • Study of Ritlecitinib Combined with Narrow Band UVB Light Therapy Compared to Ritlecitinib Alone in Adults with Vitiligo

    Recruiting

    2 1 1 1
    France

  • Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endotracheal intubation
    Investigated Drugs:
    • Remifentanil Hydrochloride
    • Rocuronium Bromide
    Denmark Sweden

  • Study of Colchicine to Reduce Complications in People with Type 1 Diabetes and High Blood Sugar Variability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Colchicine
    The Netherlands

  • Study of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels

    Recruiting

    3 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Patiromer
    Italy

  • Study of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin

    Recruiting

    2 1 1
    Investigated Drugs:
    • IMMUNOSTEM
    Italy
Previous Page
1 … 146 147 148 149 150 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!